FDA refuses to review Moderna’s mRNA flu vaccine application
February 11, 2026
The U.S. Food and Drug Administration (FDA) refused to consider Moderna’s application for a new flu vaccine using mRNA technology, the company announced Tuesday, a decision that could delay the introduction of a shot designed to offer stronger protection for older adults. Moderna said it received what’s known as a ‘refusal-to-file’ (RTF) letter from the […]